Vaccines
Neoantigens Revive Vaccine Opportunities in Immuno-Oncology
Neoantigens are novel proteins that form on cancer cells following the development of mutations in the tumor-cell DNA. These proteins are new to the immune…
ADCC and CDC Assay: Validation and Optimization
Antibody dependent cellular cytotoxicity (ADCC) is a mechanism in host immune defense where antibodies bind to an antigen on the surface of a cell, targeting…
The Broad Array of Vaccine Options for COVID-19
As we pass the two-year anniversary of the start of the coronavirus pandemic, we are reminded of where we started and how far we have…
The Benefits of Hiring the Right CRO
Short for Contract Research Organization, a CRO is a company that provides clinical research support to the pharmaceutical, biotech and medical industries on a contract…
Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb
Dr. Jeff Patrick answers questions on how BioAgilytix translated a diagnostic virus neutralization method to a quantitative relative potency assay for an anti-viral antibody.